PolyNovo Limited (CALZF)
Market Closed
5 Dec, 20:00
OTC PINK OTC PINK Primary $
0. 80
+0.05
+6.68%
$
559.24M Market Cap
- P/E Ratio
0% Div Yield
100 Volume
- Eps
$ 0.75
Previous Close Day Range
0.8 0.8
Year Range
0.62 1.82
Want to track CALZF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 78 days
Summary
CALZF closed Friday higher at $0.8, an increase of 6.68% from Thursday's close, completing a monthly increase of 6.68% or $0.05. Over the past 12 months, CALZF stock lost -23.17%.
CALZF is not paying dividends to its shareholders.
The last earnings report, released on Aug 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Feb 24, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
PolyNovo Limited (CALZF) FAQ
What is the stock price today?
The current price is $0.80.
On which exchange is it traded?
PolyNovo Limited is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is CALZF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, the market cap is 559.24M.
When is the next earnings date?
The next earnings report will release on Feb 24, 2026.
Has PolyNovo Limited ever had a stock split?
No, there has never been a stock split.
PolyNovo Limited Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Robyn Elliott B.Sc., BSc (Hons), Ph.D. CEO | OTC PINK Exchange | AU000000PNV0 ISIN |
| AU Country | 282 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
PolyNovo Limited is an innovative company focused on the development of medical devices, with a global presence that includes the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and other international markets. The company’s key product is the NovoSorb Biodegradable Temporising Matrix, a pioneering solution designed for the management of fully debrided clean surgical wounds. Originating as Calzada Limited, the company underwent a rebranding to PolyNovo Limited in November 2014. Incorporated in 1998, PolyNovo has its headquarters in Port Melbourne, Australia, marking its journey from a national entity into a respected player in the global medical devices industry.
Products and Services
- NovoSorb Biodegradable Temporising Matrix: A revolutionary product designed for the temporary closure of large surgical wounds. This biodegradable matrix aids in the management of wounds until they are ready for physiological closure, ensuring a safer and more effective healing process.
- Hernia Devices: PolyNovo is actively involved in the development of devices aimed at hernia repair. This includes solutions for ventral hernia and complex abdominal wall reconstruction, addressing a critical need in surgical interventions for hernia patients.
- NovoSorb Dermal Beta Cell Implant: This innovative implant is designed to host pancreatic islet cells within the skin. Its development represents a potentially significant advancement in the treatment of diabetes, offering a novel approach to islet cell implantation.
- NovoSorb MTX: Aimed at the treatment of complex wounds, NovoSorb MTX is under development to address a broad spectrum of wound types. This product highlights PolyNovo's commitment to expanding its portfolio to meet the diverse needs of wound care.
- Plastics and Reconstructive Device Product: PolyNovo is also developing products in the plastics and reconstructive surgery arena, signaling its entry into this highly specialized sector of medical devices. While specific details are under wraps, the company’s efforts in this area indicate a broadening scope of application for its biodegradable matrix technology.
Contact Information
Address: 320 Lorimer Street
Phone: 61 3 8681 4050
Website: https://polynovo.com
2025 © Marketlog. All Rights Reserved.
